Gene therapy shows clinical benefit in patients with a debilitating disorder caused by HPV
An NCI clinical trial showed that an experimental gene therapy called PRGN-2012 may be an effective treatment for recurrent respiratory papillomatosis, which is caused by HPV 6 and HPV 11.